Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1693 to 1702 of 1702 entries
Sorted by: Best Match Show Resources per page
Peer review of the pesticide risk assessment of the active substance .

EFSA journal. European Food Safety Authority

, Anastassiadou M, Arena M, Auteri D, Brancato A, Bura L, Carrasco Cabrera L, Chaideftou E, Chiusolo A, Crivellente F, De Lentdecker C, Egsmose M, Fait G, Greco L, Ippolito A, Istace F, Jarrah S, Kardassi D, Leuschner R, Lostia A, Lythgo C, Magrans O, Mangas I, Miron I, Molnar T, Padovani L, Parra Morte JM, Pedersen R, Reich H, Santos M, Sharp R, Szentes C, Terron A, Tiramani M, Vagenende B, Villamar-Bouza L.
PMID: 33193870
EFSA J. 2020 Nov 05;18(11):e06293. doi: 10.2903/j.efsa.2020.6293. eCollection 2020 Nov.

The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authorities of the rapporteur Member State The Netherlands and co-rapporteur Member State Germany for the pesticide active substance

Cite
, Anastassiadou M, Arena M, et al. Peer review of the pesticide risk assessment of the active substance . EFSA J. 2020;18(11):e06293doi: 10.2903/j.efsa.2020.6293.
, Anastassiadou, M., Arena, M., Auteri, D., Brancato, A., Bura, L., Carrasco Cabrera, L., Chaideftou, E., Chiusolo, A., Crivellente, F., De Lentdecker, C., Egsmose, M., Fait, G., Greco, L., Ippolito, A., Istace, F., Jarrah, S., Kardassi, D., Leuschner, R., Lostia, A., Lythgo, C., Magrans, O., Mangas, I., Miron, I., Molnar, T., Padovani, L., Parra Morte, J. M., Pedersen, R., Reich, H., Santos, M., Sharp, R., Szentes, C., Terron, A., Tiramani, M., Vagenende, B., & Villamar-Bouza, L. (2020). Peer review of the pesticide risk assessment of the active substance . EFSA journal. European Food Safety Authority, 18(11), e06293. https://doi.org/10.2903/j.efsa.2020.6293
, et al. "Peer review of the pesticide risk assessment of the active substance ." EFSA journal. European Food Safety Authority vol. 18,11 (2020): e06293. doi: https://doi.org/10.2903/j.efsa.2020.6293
, Anastassiadou M, Arena M, Auteri D, Brancato A, Bura L, Carrasco Cabrera L, Chaideftou E, Chiusolo A, Crivellente F, De Lentdecker C, Egsmose M, Fait G, Greco L, Ippolito A, Istace F, Jarrah S, Kardassi D, Leuschner R, Lostia A, Lythgo C, Magrans O, Mangas I, Miron I, Molnar T, Padovani L, Parra Morte JM, Pedersen R, Reich H, Santos M, Sharp R, Szentes C, Terron A, Tiramani M, Vagenende B, Villamar-Bouza L. Peer review of the pesticide risk assessment of the active substance . EFSA J. 2020 Nov 05;18(11):e06293. doi: 10.2903/j.efsa.2020.6293. eCollection 2020 Nov. PMID: 33193870; PMCID: PMC7642828.
Copy Download .nbib Format: NLM
Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program.

American journal of clinical pathology

Ejegod DM, Pedersen H, Pedersen BT, Jonassen CM, Lie AK, Hulleberg LS, Arbyn M, Bonde J.
PMID: 34546350
Am J Clin Pathol. 2021 Sep 21; doi: 10.1093/ajcp/aqab138. Epub 2021 Sep 21.

OBJECTIVES: This study presents the clinical assessment of the Onclarity HPV Assay (Becton Dickinson) on the novel COR high-throughput instrument (Becton Dickinson) using the international guidelines in a routine setting.METHODS: Screening samples collected in BD SurePath from women aged...

Cite
Ejegod DM, Pedersen H, Pedersen BT, et al. Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program. Am J Clin Pathol. 2021;doi: 10.1093/ajcp/aqab138.
Ejegod, D. M., Pedersen, H., Pedersen, B. T., Jonassen, C. M., Lie, A. K., Hulleberg, L. S., Arbyn, M., & Bonde, J. (2021). Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program. American journal of clinical pathology, . https://doi.org/10.1093/ajcp/aqab138
Ejegod, Ditte Møller, et al. "Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program." American journal of clinical pathology vol. (2021). doi: https://doi.org/10.1093/ajcp/aqab138
Ejegod DM, Pedersen H, Pedersen BT, Jonassen CM, Lie AK, Hulleberg LS, Arbyn M, Bonde J. Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program. Am J Clin Pathol. 2021 Sep 21; doi: 10.1093/ajcp/aqab138. Epub 2021 Sep 21. PMID: 34546350.
Copy Download .nbib Format: NLM
Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death.

Pharmacological research

Wells MA, See Hoe LE, Molenaar P, Pedersen S, Obonyo NG, McDonald CI, Mo W, Bouquet M, Hyslop K, Passmore MR, Bartnikowski N, Suen JY, Peart JN, McGiffin DC, Fraser JF.
PMID: 33905863
Pharmacol Res. 2021 Jul;169:105631. doi: 10.1016/j.phrs.2021.105631. Epub 2021 Apr 24.

BACKGROUND: Heart failure is an inexorably progressive disease with a high mortality, for which heart transplantation (HTx) remains the gold standard treatment. Currently, donor hearts are primarily derived from patients following brain stem death (BSD). BSD causes activation of...

Cite
Wells MA, See Hoe LE, Molenaar P, et al. Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death. Pharmacol Res. 2021;169:105631doi: 10.1016/j.phrs.2021.105631.
Wells, M. A., See Hoe, L. E., Molenaar, P., Pedersen, S., Obonyo, N. G., McDonald, C. I., Mo, W., Bouquet, M., Hyslop, K., Passmore, M. R., Bartnikowski, N., Suen, J. Y., Peart, J. N., McGiffin, D. C., Fraser, J. F. (2021). Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death. Pharmacological research, 169105631. https://doi.org/10.1016/j.phrs.2021.105631
Wells, Matthew A, et al. "Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death." Pharmacological research vol. 169 (2021): 105631. doi: https://doi.org/10.1016/j.phrs.2021.105631
Wells MA, See Hoe LE, Molenaar P, Pedersen S, Obonyo NG, McDonald CI, Mo W, Bouquet M, Hyslop K, Passmore MR, Bartnikowski N, Suen JY, Peart JN, McGiffin DC, Fraser JF. Compromised right ventricular contractility in an ovine model of heart transplantation following 24 h donor brain stem death. Pharmacol Res. 2021 Jul;169:105631. doi: 10.1016/j.phrs.2021.105631. Epub 2021 Apr 24. PMID: 33905863.
Copy Download .nbib Format: NLM
High physical work demands have worse consequences for older workers: prospective study of long-term sickness absence among 69 117 employees.

Occupational and environmental medicine

Andersen LL, Pedersen J, Sundstrup E, Thorsen SV, Rugulies R.
PMID: 33972376
Occup Environ Med. 2021 Nov;78(11):829-834. doi: 10.1136/oemed-2020-107281. Epub 2021 May 10.

OBJECTIVE: This study investigates the role of age for the prospective association between physical work demands and long-term sickness absence (LTSA).METHODS: We followed 69 117 employees of the general working population (Work Environment and Health in Denmark study 2012-2018),...

Cite
Andersen LL, Pedersen J, Sundstrup E, et al. High physical work demands have worse consequences for older workers: prospective study of long-term sickness absence among 69 117 employees. Occup Environ Med. 2021;78(11):829-834doi: 10.1136/oemed-2020-107281.
Andersen, L. L., Pedersen, J., Sundstrup, E., Thorsen, S. V., & Rugulies, R. (2021). High physical work demands have worse consequences for older workers: prospective study of long-term sickness absence among 69 117 employees. Occupational and environmental medicine, 78(11), 829-834. https://doi.org/10.1136/oemed-2020-107281
Andersen, Lars Louis, et al. "High physical work demands have worse consequences for older workers: prospective study of long-term sickness absence among 69 117 employees." Occupational and environmental medicine vol. 78,11 (2021): 829-834. doi: https://doi.org/10.1136/oemed-2020-107281
Andersen LL, Pedersen J, Sundstrup E, Thorsen SV, Rugulies R. High physical work demands have worse consequences for older workers: prospective study of long-term sickness absence among 69 117 employees. Occup Environ Med. 2021 Nov;78(11):829-834. doi: 10.1136/oemed-2020-107281. Epub 2021 May 10. PMID: 33972376; PMCID: PMC8526881.
Copy Download .nbib Format: NLM
Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers.

Diabetologia

Schnurr TM, Jørsboe E, Chadt A, Dahl-Petersen IK, Kristensen JM, Wojtaszewski JFP, Springer C, Bjerregaard P, Brage S, Pedersen O, Moltke I, Grarup N, Al-Hasani H, Albrechtsen A, Jørgensen ME, Hansen T.
PMID: 33912980
Diabetologia. 2021 Aug;64(8):1795-1804. doi: 10.1007/s00125-021-05461-z. Epub 2021 Apr 29.

AIMS/HYPOTHESIS: The common muscle-specific TBC1D4 p.Arg684Ter loss-of-function variant defines a subtype of non-autoimmune diabetes in Arctic populations. Homozygous carriers are characterised by elevated postprandial glucose and insulin levels. Because 3.8% of the Greenlandic population are homozygous carriers, it is...

Cite
Schnurr TM, Jørsboe E, Chadt A, et al. Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers. Diabetologia. 2021;64(8):1795-1804doi: 10.1007/s00125-021-05461-z.
Schnurr, T. M., Jørsboe, E., Chadt, A., Dahl-Petersen, I. K., Kristensen, J. M., Wojtaszewski, J. F. P., Springer, C., Bjerregaard, P., Brage, S., Pedersen, O., Moltke, I., Grarup, N., Al-Hasani, H., Albrechtsen, A., Jørgensen, M. E., & Hansen, T. (2021). Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers. Diabetologia, 64(8), 1795-1804. https://doi.org/10.1007/s00125-021-05461-z
Schnurr, Theresia M, et al. "Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers." Diabetologia vol. 64,8 (2021): 1795-1804. doi: https://doi.org/10.1007/s00125-021-05461-z
Schnurr TM, Jørsboe E, Chadt A, Dahl-Petersen IK, Kristensen JM, Wojtaszewski JFP, Springer C, Bjerregaard P, Brage S, Pedersen O, Moltke I, Grarup N, Al-Hasani H, Albrechtsen A, Jørgensen ME, Hansen T. Physical activity attenuates postprandial hyperglycaemia in homozygous TBC1D4 loss-of-function mutation carriers. Diabetologia. 2021 Aug;64(8):1795-1804. doi: 10.1007/s00125-021-05461-z. Epub 2021 Apr 29. PMID: 33912980; PMCID: PMC8245392.
Copy Download .nbib Format: NLM
Review of the existing maximum residue levels for 8-hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005.

EFSA journal. European Food Safety Authority

, Anastassiadou M, Bellisai G, Bernasconi G, Brancato A, Carrasco Cabrera L, Ferreira L, Greco L, Jarrah S, Kazocina A, Leuschner R, Magrans JO, Miron I, Nave S, Pedersen R, Reich H, Santos M, Scarlato AP, Theobald A, Vagenende B, Verani A.
PMID: 33936311
EFSA J. 2021 Apr 26;19(4):e06566. doi: 10.2903/j.efsa.2021.6566. eCollection 2021 Apr.

According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance 8-hydroxyquinoline. To assess the occurrence of 8-hydroxyquinoline residues in plants, processed commodities,...

Cite
, Anastassiadou M, Bellisai G, et al. Review of the existing maximum residue levels for 8-hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005. EFSA J. 2021;19(4):e06566doi: 10.2903/j.efsa.2021.6566.
, Anastassiadou, M., Bellisai, G., Bernasconi, G., Brancato, A., Carrasco Cabrera, L., Ferreira, L., Greco, L., Jarrah, S., Kazocina, A., Leuschner, R., Magrans, J. O., Miron, I., Nave, S., Pedersen, R., Reich, H., Santos, M., Scarlato, A. P., Theobald, A., Vagenende, B., & Verani, A. (2021). Review of the existing maximum residue levels for 8-hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005. EFSA journal. European Food Safety Authority, 19(4), e06566. https://doi.org/10.2903/j.efsa.2021.6566
, et al. "Review of the existing maximum residue levels for 8-hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005." EFSA journal. European Food Safety Authority vol. 19,4 (2021): e06566. doi: https://doi.org/10.2903/j.efsa.2021.6566
, Anastassiadou M, Bellisai G, Bernasconi G, Brancato A, Carrasco Cabrera L, Ferreira L, Greco L, Jarrah S, Kazocina A, Leuschner R, Magrans JO, Miron I, Nave S, Pedersen R, Reich H, Santos M, Scarlato AP, Theobald A, Vagenende B, Verani A. Review of the existing maximum residue levels for 8-hydroxyquinoline according to Article 12 of Regulation (EC) No 396/2005. EFSA J. 2021 Apr 26;19(4):e06566. doi: 10.2903/j.efsa.2021.6566. eCollection 2021 Apr. PMID: 33936311; PMCID: PMC8072995.
Copy Download .nbib Format: NLM
Indirect comparison of efficacy of dupilumab .

ERJ open research

Prætorius K, Henriksen DP, Schmid JM, Printzlau P, Pedersen L, Madsen H, Andersson EA, Madsen LK, Chawes BL.
PMID: 34476242
ERJ Open Res. 2021 Aug 31;7(3). doi: 10.1183/23120541.00306-2021. eCollection 2021 Jul.

No abstract available.

Cite
Prætorius K, Henriksen DP, Schmid JM, et al. Indirect comparison of efficacy of dupilumab . ERJ Open Res. 2021;7(3)doi: 10.1183/23120541.00306-2021.
Prætorius, K., Henriksen, D. P., Schmid, J. M., Printzlau, P., Pedersen, L., Madsen, H., Andersson, E. A., Madsen, L. K., & Chawes, B. L. (2021). Indirect comparison of efficacy of dupilumab . ERJ open research, 7(3), . https://doi.org/10.1183/23120541.00306-2021
Prætorius, Katrine, et al. "Indirect comparison of efficacy of dupilumab ." ERJ open research vol. 7,3 (2021). doi: https://doi.org/10.1183/23120541.00306-2021
Prætorius K, Henriksen DP, Schmid JM, Printzlau P, Pedersen L, Madsen H, Andersson EA, Madsen LK, Chawes BL. Indirect comparison of efficacy of dupilumab . ERJ Open Res. 2021 Aug 31;7(3). doi: 10.1183/23120541.00306-2021. eCollection 2021 Jul. PMID: 34476242; PMCID: PMC8405862.
Copy Download .nbib Format: NLM
Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study.

Clinical epidemiology

Arendt LH, Pedersen LH, Pedersen L, Ovesen PG, Henriksen TB, Lindhard MS, Olsen J, Sørensen HT, Ramlau-Hansen CH.
PMID: 34345185
Clin Epidemiol. 2021 Jul 26;13:615-626. doi: 10.2147/CLEP.S298748. eCollection 2021.

PURPOSE: To study the occurrence of major congenital abnormalities in children of women with type 1 and type 2 diabetes and investigate the association between glycated haemoglobin (HbA1c) and major congenital malformations according to type 1 diabetes and type...

Cite
Arendt LH, Pedersen LH, Pedersen L, et al. Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study. Clin Epidemiol. 2021;13:615-626doi: 10.2147/CLEP.S298748.
Arendt, L. H., Pedersen, L. H., Pedersen, L., Ovesen, P. G., Henriksen, T. B., Lindhard, M. S., Olsen, J., Sørensen, H. T., & Ramlau-Hansen, C. H. (2021). Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study. Clinical epidemiology, 13615-626. https://doi.org/10.2147/CLEP.S298748
Arendt, Linn Håkonsen, et al. "Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study." Clinical epidemiology vol. 13 (2021): 615-626. doi: https://doi.org/10.2147/CLEP.S298748
Arendt LH, Pedersen LH, Pedersen L, Ovesen PG, Henriksen TB, Lindhard MS, Olsen J, Sørensen HT, Ramlau-Hansen CH. Glycemic Control in Pregnancies Complicated by Pre-Existing Diabetes Mellitus and Congenital Malformations: A Danish Population-Based Study. Clin Epidemiol. 2021 Jul 26;13:615-626. doi: 10.2147/CLEP.S298748. eCollection 2021. PMID: 34345185; PMCID: PMC8325058.
Copy Download .nbib Format: NLM
Promoting health equity in the health-care system: How can we identify potentially vulnerable patients?.

Scandinavian journal of public health

Johnsen AT, Flink CE, Winther KP, Markussen AR, Lund L, Pedersen I, Rix BA, Kehlet KH.
PMID: 34903121
Scand J Public Health. 2021 Dec 13;14034948211059720. doi: 10.1177/14034948211059720. Epub 2021 Dec 13.

BACKGROUND: There is documented social inequality in cancer. The health-care system may contribute to health equity by targeting interventions to potentially vulnerable patients who may be at risk of not receiving optimal treatment and care.AIM: This study aimed to...

Cite
Johnsen AT, Flink CE, Winther KP, et al. Promoting health equity in the health-care system: How can we identify potentially vulnerable patients?. Scand J Public Health. 2021;14034948211059720doi: 10.1177/14034948211059720.
Johnsen, A. T., Flink, C. E., Winther, K. P., Markussen, A. R., Lund, L., Pedersen, I., Rix, B. A., & Kehlet, K. H. (2021). Promoting health equity in the health-care system: How can we identify potentially vulnerable patients?. Scandinavian journal of public health, 14034948211059720. https://doi.org/10.1177/14034948211059720
Johnsen, Anna Thit, et al. "Promoting health equity in the health-care system: How can we identify potentially vulnerable patients?." Scandinavian journal of public health vol. (2021): 14034948211059720. doi: https://doi.org/10.1177/14034948211059720
Johnsen AT, Flink CE, Winther KP, Markussen AR, Lund L, Pedersen I, Rix BA, Kehlet KH. Promoting health equity in the health-care system: How can we identify potentially vulnerable patients?. Scand J Public Health. 2021 Dec 13;14034948211059720. doi: 10.1177/14034948211059720. Epub 2021 Dec 13. PMID: 34903121.
Copy Download .nbib Format: NLM
Modification of the existing maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries.

EFSA journal. European Food Safety Authority

, Anastassiadou M, Bellisai G, Bernasconi G, Brancato A, Carrasco Cabrera L, Ferreira L, Greco L, Jarrah S, Kazocina A, Leuschner R, Magrans JO, Miron I, Nave S, Pedersen R, Reich H, Santos M, Scarlato AP, Theobald A, Vagenende B, Verani A.
PMID: 33777238
EFSA J. 2021 Mar 23;19(3):e06499. doi: 10.2903/j.efsa.2021.6499. eCollection 2021 Mar.

In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Syngenta Agro GmbH submitted a request to the competent national authority in Germany to modify the existing maximum residue levels (MRL) for the active substance cyprodinil in...

Cite
, Anastassiadou M, Bellisai G, et al. Modification of the existing maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries. EFSA J. 2021;19(3):e06499doi: 10.2903/j.efsa.2021.6499.
, Anastassiadou, M., Bellisai, G., Bernasconi, G., Brancato, A., Carrasco Cabrera, L., Ferreira, L., Greco, L., Jarrah, S., Kazocina, A., Leuschner, R., Magrans, J. O., Miron, I., Nave, S., Pedersen, R., Reich, H., Santos, M., Scarlato, A. P., Theobald, A., Vagenende, B., & Verani, A. (2021). Modification of the existing maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries. EFSA journal. European Food Safety Authority, 19(3), e06499. https://doi.org/10.2903/j.efsa.2021.6499
, et al. "Modification of the existing maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries." EFSA journal. European Food Safety Authority vol. 19,3 (2021): e06499. doi: https://doi.org/10.2903/j.efsa.2021.6499
, Anastassiadou M, Bellisai G, Bernasconi G, Brancato A, Carrasco Cabrera L, Ferreira L, Greco L, Jarrah S, Kazocina A, Leuschner R, Magrans JO, Miron I, Nave S, Pedersen R, Reich H, Santos M, Scarlato AP, Theobald A, Vagenende B, Verani A. Modification of the existing maximum residue levels for cyprodinil in blueberries, cranberries, currants and gooseberries. EFSA J. 2021 Mar 23;19(3):e06499. doi: 10.2903/j.efsa.2021.6499. eCollection 2021 Mar. PMID: 33777238; PMCID: PMC7985993.
Copy Download .nbib Format: NLM
Showing 1693 to 1702 of 1702 entries